20-hydroxyecdysone as a human lymphocyte and neutrophil modulator: In vitro evaluation

Archives of Insect Biochemistry and Physiology

Volumn 41, Issue 3, 1999, Pages 156-161

  Trenin, Dmitry S ^a,b   Volodin, Vladimir V ^a  

^a INSTITUTE OF BIOLOGY   (Russian Federation)

^b Diagn Ctr for Lab Diagnostics   (Russian Federation)

Author keywords

1 oxy 4 oxoadamantane; 20 hydroxyecdysone; CD2 presentation; Levamisol; Respiratory burst

Indexed keywords

INSECTA; OXY;

CD2 ANTIGEN; ECDYSTERONE; IMMUNOLOGICAL ADJUVANT;

ARTICLE; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; IMMUNOLOGY; IN VITRO STUDY; NEUTROPHIL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD2; ECDYSTERONE; HUMANS; MOLECULAR STRUCTURE; NEUTROPHILS; T-LYMPHOCYTES;

EID: 0032618985     PISSN: 07394462     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6327(1999)41:3<156::AID-ARCH7>3.0.CO;2-Q     Document Type: Article

References (28)

1. Auteri A, Pasqui AL, Bruni F, Saletti M. 1991. Effect of PGT/ 1A, a new immunostimulating agent, on some aspects of immune response. In vitro study. Symposium of the International Association of Biological Standardization. Standardization of the immunopharmacology of natural and synthetic immunomodulators. Satellite symposium of the 5th International Conference on Immunopharmacology, Annecy, France, May 15-17, 1991.
2. Boiko SS, Zherdev VP, Kislyak NA. 1991. Clinical pharmacokinetics of kemantane. Pharmacol Toxicol 54:57-59 (Rus).
3. Bumagina TH, Shmelev EI. 1981. Activated NBT test in identification of phagocytosis impairment in patients with inflammatory diseases of lungs. Laboratornoje delo 4:200-202 (Rus).
4. Carreras MC, Pargament GA, Catz SD, Poderoso JJ, Boveris A. 1994. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett 341:65-68.
5. Chermnykh NS, Shimanovsky NL, Shutko GV, Syrov VN. 1988. Effects of methandrostenolone and ecdysterone on physical endurance of animals and protein metabolism in the skeletal muscles. Pharmacol Toxicol 51:57-60 (Rus).
6. Dawson RMC, Elliott DC, Elliott WH, Jones KM. 1991. Data for Biochemical Research. Moscow, "Mir," Russian translation from the Third Edition. Oxford: Clarendon Press, 1986.
7. Dyumaev KM, Voronina TA, Smirnov LD. 1995. The antioxidants in the prophylaxis and treatment of the central neural system pathology. The edition of the Institute of Biochemistry and Medicinal Chemistry RAMS, Moscow (Rus).
8. Halvorsen R, Leivestad T, Gaudernack G, Thorsby E. 1988. Induction of interleukin-2 production in CD4+ and CD8+ T-cell subsets after activation via CD3 and CD2. Scand. J Immunol 28:449-455.
9. Khaidukov SV. 1992. The mode of action of muramylpeptides: flow cytometric study. PhD dissertation, Moscow (Rus).
10. Khaitov RM, Pinegin BV. 1995. Prospects to study the functions of phagocytes. Immunology 3:6-10 (Rus).
11. Klimov VV. 1981. Reserve of the phagocytosis system in infants with acute pneumonia and local bacterial infection. Pediatrics 11:45-46 (Rus).
12. Ktsoyan LA, Karganyan GS, Aeloyan DV , Avakyan AG. 1989. The influence of adrenergic compounds on Erosette formation in patients with functional and inflammatory colon diseases. The First Soviet Immunologic Congress 2:327 (Rus).
13. Kurmukov AG, Yermishina OA. 1991. Effect of ecdysterone on experimental arrhythmias, changes in haemodynamics and contractility of the myocardium produced by the coronary artery occlusion. Pharmacol Toxicol 54:27-29 (Rus).
14. Kuzmitsky BB, Golubeva MB, Konoplya NA, Kovganko NV, Achrem AA. 1990. New opportunities of search for immunomodulators among compounds with steroidal structure.Pharmacol Toxicol 53:20-22 (Rus).
15. Lasareva DN, Alyoekhin EK. 1985. Immunostimulants. Moscow, "Medicine" (Rus).
16. Malishevsky MV, Zhmurov VA, Kgapon LI, Kashuba EA. 1992. The influence of the combined therapy by emoxipin and propranolol upon the functional and metabolic activity of neutrophils of essential hypertension patients. The Bulletin of the Russian Scientific Centre on the Safety of Biologicaly Active Substances. p 96-104 (Rus).
17. Nevidimova TI. 1989. The immuno-active substances in the treatment of psychiatric diseases. The First Soviet Immunologic Congress. vol 2, p 341 (Rus).
18. Nizhnij SV, Dmitrieva NV. 1985.The screening of physiologically active substances. Moscow, "Medicine" (Rus).
19. Osynska LPh, Saad LM, Kholodova YuD. 1992. Antiradical properties and antioxidative activity of ecdysterone. Ukran Biochem J 64:114-117 (Rus).
20. Paltsev MA, Ivanov AA. 1995. Cell-cell interactions. Moscow, "Medicine" (Rus).
21. Petrov RV, Khaitov RM, Pinegin BV, Oradovskaya IV, Eryoemina OF, Saidov MZ. 1992. Human immune profile screening. Immunology 6:51-62 (Rus).
22. Petrov VK, Darmogray VN, Sysykin AA, Potekhinskij SM, Ukhova AU. 1996. Some aspects of phytoecdysteroids study in experiment and clinic. The 3rd Russian Congress "The Man and the Drug," Moscow, 16-20 April 1996.
23. Sergeeva SA, Krasnykh LM, Ivanova IA, Lasareva AI, Krasnykh MN. 1992. The pharmacological activity of adamantane derivatives. The Bulletin of the Russian Scientific Centre on the Safety of Biologicaly Active Substances 2:41-63 (Rus).
24. Shigaev NI. 1989. The influence of dopaminergic and adrenergic substances on the immune functions and immunostimulation. MD dissertation. Chelyabinsk (Rus).
25. Syrov VN, Nasyrova SS, Khushbaktova ZA. 1997. The results of experimental study of phytoecdysteroids as erythropoiesis stimulators in laboratory animals. Exp Clin Pharmacol 60:41-44 (Rus).
26. Twomey BM, Dale MM. 1992. Cyclooxygenase independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochem Pharmacol 43:413-418.
27. Vladimirov YuA, Sherstnyoev MP. 1989. The cellular chemiluminescence in vertebrates: scientific and technical results. Moscow. Biophysics Series 24.
28. Yakovleva NN, Nikonova MF, Litvina MM, Martin YuV, Yarilin AA, Sokurenko SI. 1994. Classical and alternative pathways of T-lymphocyte activation in chronic bronchitis. Immunology 1:22-26 (Rus).